Literature DB >> 22738056

Distribution and processing of a disintegrin and metalloproteinase with thrombospondin motifs-4, aggrecan, versican, and hyaluronan in equine digital laminae.

Erica Pawlak1, Le Wang, Philip J Johnson, Gerard Nuovo, Almaz Taye, James K Belknap, Dominique Alfandari, Samuel J Black.   

Abstract

OBJECTIVE: To determine the expression and distribution of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4), its substrates aggrecan and versican, and their binding partner hyaluronan in laminae of healthy horses. SAMPLE: Laminae from the forelimb hooves of 8 healthy horses. PROCEDURES: Real-time quantitative PCR assay was used for gene expression analysis. Hyaluronidase, chondroitinase, and keratanase digestion of lamina extracts combined with SDS-PAGE and western blotting were used for protein and proteoglycan analysis. Immunofluorescent and immunohistochemical staining of tissue sections were used for protein and hyaluronan localization.
RESULTS: Genes encoding ADAMTS-4, aggrecan, versican, and hyaluronan synthase II were expressed in laminae. The ADAMTS-4 was predominantly evident as a 51-kDa protein bearing a catalytic site neoepitope indicative of active enzyme and in situ activity, which was confirmed by the presence of aggrecan and versican fragments bearing ADAMTS-4 cleavage neoepitopes in laminar protein extracts. Aggrecan, versican, and hyaluronan were localized to basal epithelial cells within the secondary epidermal laminae. The ADAMTS-4 localized to these cells but was also present in some cells in the dermal laminae. CONCLUSIONS AND CLINICAL RELEVANCE: Within digital laminae, versican exclusively and aggrecan primarily localized within basal epithelial cells and both were constitutively cleaved by ADAMTS-4, which therefore contributed to their turnover. On the basis of known properties of these proteoglycans, it is possible that they can protect the basal epithelial cells of horses from biomechanical and concussive stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22738056      PMCID: PMC3535468          DOI: 10.2460/ajvr.73.7.1035

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  38 in total

Review 1.  Structure and function of aggrecan.

Authors:  Chris Kiani; Liwen Chen; Yao Jiong Wu; Albert J Yee; Burton B Yang
Journal:  Cell Res       Date:  2002-03       Impact factor: 25.617

2.  Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.

Authors:  J D Sandy; J Westling; R D Kenagy; M L Iruela-Arispe; C Verscharen; J C Rodriguez-Mazaneque; D R Zimmermann; J M Lemire; J W Fischer; T N Wight; A W Clowes
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

3.  Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.

Authors:  Masahide Kashiwagi; Jan J Enghild; Christi Gendron; Clare Hughes; Bruce Caterson; Yoshifumi Itoh; Hideaki Nagase
Journal:  J Biol Chem       Date:  2003-12-08       Impact factor: 5.157

4.  Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.

Authors:  Gui Gao; Jennifer Westling; Vivian P Thompson; Troy D Howell; Paul E Gottschall; John D Sandy
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

5.  Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.

Authors:  J D Sandy; C Verscharen
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

Review 6.  Versican: a versatile extracellular matrix proteoglycan in cell biology.

Authors:  Thomas N Wight
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

Review 7.  Stem cells of the skin epithelium.

Authors:  Laura Alonso; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

8.  ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.

Authors:  Jennifer Westling; Paul E Gottschall; Vivian P Thompson; Amber Cockburn; George Perides; Dieter R Zimmermann; John D Sandy
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

Review 9.  Mammalian hyaluronan synthases.

Authors:  Naoki Itano; Koji Kimata
Journal:  IUBMB Life       Date:  2002-10       Impact factor: 3.885

10.  Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network.

Authors:  Ping Wang; Micky Tortorella; Kristen England; Anne-Marie Malfait; Gary Thomas; Elizabeth C Arner; Duanqing Pei
Journal:  J Biol Chem       Date:  2004-01-26       Impact factor: 5.157

View more
  4 in total

1.  Effects of cleavage by a disintegrin and metalloproteinase with thrombospondin motifs-4 on gene expression and protein content of versican and aggrecan in the digital laminae of horses with starch gruel-induced laminitis.

Authors:  Le Wang; Erica Pawlak; Philip J Johnson; James K Belknap; Dominique Alfandari; Samuel J Black
Journal:  Am J Vet Res       Date:  2012-07       Impact factor: 1.156

2.  Use of laser capture microdissection for the assessment of equine lamellar basal epithelial cell signalling in the early stages of laminitis.

Authors:  B S Leise; M R Watts; S Roy; A S Yilmaz; H Alder; J K Belknap
Journal:  Equine Vet J       Date:  2014-08-19       Impact factor: 2.888

3.  Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators.

Authors:  Jessica M Gilbertie; Julie M Long; Alicia G Schubert; Alix K Berglund; Thomas P Schaer; Lauren V Schnabel
Journal:  Front Vet Sci       Date:  2018-07-04

4.  Expression and activity of collagenases in the digital laminae of horses with carbohydrate overload-induced acute laminitis.

Authors:  L Wang; E A Pawlak; P J Johnson; J K Belknap; D Alfandari; S J Black
Journal:  J Vet Intern Med       Date:  2013-11-25       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.